Pathogenesis of allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 99, Issue 2, 1997, Pages

  Baraniuk, James N ^a,b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

adhesion molecules; Allergic rhinitis; eosinophils; inflammatory response; mast cell

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BRADYKININ; CELL ADHESION MOLECULE; CHEMOATTRACTANT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYTOKINE; ENDOTHELIN 1; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HISTAMINE; IMMUNOGLOBULIN E; IPRATROPIUM BROMIDE; METHACHOLINE; STEROID;

ALLERGIC RHINITIS; ARTICLE; EOSINOPHIL; HUMAN; IMMUNOTHERAPY; INTRANASAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MAST CELL; NEUROGENIC INFLAMMATION; NONHUMAN; NOSE MUCOSA; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; SENSITIZATION; SKIN TEST; TOPICAL DRUG ADMINISTRATION;

EID: 0031058390     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70125-8     Document Type: Article

References (69)

1. Holm AF, Fokkens WJ, Godthelp T, Mulder PG, Vroom TM, Rjintejes E. Effect of 3 months' nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis. Allergy 1995;50:204-9.
2. Schou C. Allergens in rhinitis: B- and T-cell epitopes of allergen molecules. Clin Exp Allergy 1995;25:10-4.
3. Borish L, Rosenwasser L. Update on cytokines. J Allergy Clin Immunol 1996;97:719-34.
4. James DC, Kay AB. Are you TH-1 or TH-2? Clin Exp Allergy 1995;25:389-90.
5. Takenaka H, Zhang K, Diaz-Sanchez D, Tsein A, Sackson A. Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: direct effects on B cell IgE production. J Allergy Clin Immunol 1995;95:103-15.
6. Diaz-Sanchez D, Tsien A, Casillas A, Dotson AR, Sackson A. Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. J Allergy Clin Immunol 1996;98:114-23.
7. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human mast cells based on cytokines content. J Immunol 1995;155:297-307.
8. Bradding P, Mediwake R, Feather IH, et al. TNF-α is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin Exp Allergy 1995;25:406-15.
9. Pawankar RU, Okuda M, Hasegawa S, et al. Interleukin-13 expression in the nasal mucosal of perennial allergic rhinitis. Am J Respir Crit Care Med 1995;152:2059-67.
10. Juluisson S, Aldenborg F, Enerback L. Protease content of mast cells of nasal mucosa: effects of natural allergen exposure and of local corticosteroid treatment. Allergy 1995;50:15-22.
11. Kawabori Y, Kanai N, Tosho T. Proliferative activity of mast cells in allergic nasal mucosa. Clin Exp Allergy 1995;25:173-8.
12. Galli SJ. New concepts about the mast cell. N Engl J Med 1993;328:257-65.
13. Sim TC, Reece LM, Hilsmeier KA, Grant JA, Alam R. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med 1995;152:927-33.
14. Terada N, Kono A, Togawa K. Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy. J Allergy Clin Immunol 1994;94:629-42.
15. Naclerio RM, Baroody FM, Kagey-Sobotka A, Lichtenstein LM. Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol 1994;94:1303-9.
16. Sommerhof CP, Caughey GH, Finkbeiner WE, Lazarus SC, Basbaum CB, Nadel JA. Mast cell chymase: a potent secretagogue for airway gland serous cells. J Immunol 1989:142:2450-6.
17. Holgate ST, Bradding BM, Sampson AP. Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol 1996;98:1-13.
18. Erjefalt I, Persson CGA. Allergen, bradykinin, and capsaicin increase outward but not inward macromolecular permeability of guinea-pig tracheobronchial mucus. Clin Exp Allergy 1991;21:217-24.
19. Simons E, Simons K, editors. Histamine and H1-antagonists in allergic disease. New York: Marcel Dekker, 1996.
20. Iriyoshi N, Takeuchi K, Yuta A, Ukai K, Sakakura Y. Increased pathology of allergic rhinitis: expression of histamine H1 receptor mRNA in allergic rhinitis. Clin Exp Allergy 1996;26:379-85.
21. Okayma M, Baraniuk JN, Hausfeld JN, Merida M, Kaliner MA. Characterization and autoradiographic localization of histamine H1 receptors in human nasal turbinates. J Allergy Clin Immunol 1992;89:1144-50.
22. Okayama M, Yamauchi K, Sekizawa K, et al. Localization of histamine N-methyltransferase messenger RNA in human nasal mucosa. J Allergy Clin Immunol 1995;95:96-102.
23. Raphael GD, Meredith SD, Baraniuk JN, Druce HM, Banks SM, Kaliner MA. The pathophysiology of rhinitis. II. Assessment of the sources of protein in histamine-induced nasal secretions. Am Rev Respir Dis 1989;139:791-800.
24. Baraniuk JN. Neuropeptide pharmacology. In: Townley RG, Agarwal DK, editors. Immunopharmacology of the respiratory tract: clinical allergy and immunology. New York: Marcel Dekker, 1996:575-603.
25. McDonald DM. Neurogenic inflammation in the respiratory tract: actions of sensory nerve mediators on blood vessels and epithelium of the airway mucosa. Am Rev Respir Dis 1987;136:865-72.
26. Svensson C, Andersson M, Greiff L, Alkner U, Persson CGA. Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis. Clin Exp Allergy 1995;25:942-50.
27. Stjarne P, Lacroix JS, Anggard A, Lundberg JM. Compartment analysis of vascular effects of neuropeptides and capsaicin in the pig nasal mucosa. Acta Physiol Scand 1991;141:335-42.
28. Joos GF, Germonpre PR, Pauwels RA. Neurogenic inflammation in human airways: is it important? Thorax 1995;50:217-9.
29. Mossiman BL, White MV, Hohman RJ, Goldrich MS, Kaulbach HC, Kaliner MA. Substance P, calcitonin-gene related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol 1993;92:95-104.
30. Fajac I, Braunstein G, Ickovic MR, Lacronique J, Frossard N. Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis. Allergy 1995;50:970-5.
31. Okamoto Y, Shirotori K, Kudo K, et al. Cytokine expression after the topical administration of substance P to human nasal mucosa: the role of substance P in nasal allergy. J Immunol 1993;151:4391-8.
32. Sanico AM, Atsuta S, Togias A. Leukocyte influx after capsaicin nasal challenge is a dose dependent phenomenon. J Allergy Clin Immunol 1996;97:430.
33. Baraniuk JN, Silver PB, Kaliner MA, Barnes PJ. Effects of ipratropium bromide on bradykinin nasal provocation in humans. Clin Exp Allergy 1994;14:724-9.
34. Mullol J, Baraniuk JN, Logun C, et al. Ml and M3 muscarinic antagonists inhibit human nasal glandular secretion in vitro. J Appl Physiol 1992;73:2069-73.
35. Baraniuk JN, Kaliner MA, Barnes PJ. Localization of m3 muscarinic receptor mRNA in human nasal mucosa. Am J Rhinol 1992;6:145-8.
36. Togias A, Naclerio RM, Proud D, et al. Studies on allergic and nonallergic nasal inflammation. J Allergy Clin Immunol 1988;81:782-90.
37. Gosset P, Malaquin F, Delnest Y, et al. Interleukin 6 and interleukin-1α production is associated with antigen induced late nasal response. J Allergy Clin Immunol 1993;92:878-90.
38. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 1994;94:427-38.
39. Valent P. The phenotype of human eosinophils, basophils and mast cells. J Allergy Clin Immunol 1994;94:1177-83.
40. Lee BJ, Naclerio RM, Bochner BS, Taylor RM, Lim MC, Baroody FM. Nasal challenge with allergen upregulates the local expression of vascular endothelial adhesion molecules. J Allergy Clin Immunol 1994;94:1006-16.
41. Feather IH, Wilson SJ. Eosinophils in rhinitis. In: Busse WW, Holgate ST, editors. Asthma and rhinitis. Oxford, England: Blackwell Scientific, 1995:347-66.
42. Moqbel R, Levi-Schaffer F, Kay AB. Cytokine generation by eosinophils. J Allergy Clin Immunol 1994;94:1183-9.
43. Wardlaw AJ, Symon FS, Walsh GM. Eosinophil adhesion in allergic inflammation. J Allergy Clin Immunol 1994;94:1163-7.
44. Ponath PD, Qin S, Ringler DJ, et al. Cloning of the human eosinophil chemoattractant, eotaxin: expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604-12.
45. Ohno I, Lea RG, Flanders KC, et al. Eosinophils in chronically inflammed human upper airway tissues express transforming growth factor β1 gene (TGF β1). J Clin Invest 1992;89:1662-8.
46. Pawankar RU, Okuda M, Okubo K, Ra C. Lymphocyte subsets in the nasal mucosa in perennial allergic rhinitis. Am J Respir Crit Care Med 1995;152:2049-58.
47. Calderon MA, Lozewicz S, Prior A, Jordan S, Trigg CJ. Davies RJ. Lymphocyte infiltration and thickness of the nasal mucous membrane in perennial and allergic seasonal rhinitis. J Allergy Clin Immunol 1994;93:635-43.
48. Kuna P, Lazarovich M, Kaplan AP. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:104-12.
49. Pawankar RU, Okuda M, Suzuki K, Okumura K, Ra C. Phenotypic and molecular characteristics of nasal mucosal gamma delta T cells in allergic and infectious rhinitis. Am J Respir Crit Care Med 1996;153:1655-65.
50. Meredith SD, Raphael GD, Baraniuk JN, Banks SM, Kaliner MA. The pathophysiology of rhinitis. III. The control of IgG secretion. J Allergy Clin Immunol 1989;84:920-30.
51. Igarashi Y, Goldrich MS, Kaliner MA, Irani AMA, Schwartz LB, White MV. Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects. J Allergy Clin Immunol 1995;95:716-25.
52. Nonaka M, Nonaka R, Jordana M, Dolovich J. GM-CSF, IL-8, IL-1R, TNF-αR, and HLA-DR in nasal epithelial cells in allergic rhinitis. Am J Respir Crit Care Med 1996;153:1675-81.
53. Kenney JS, Baker C, Welch MR, Altman LC. Synthesis of interleukin-1α, interleukin-6, and interleukin-8 by cultured human nasal epithelial cells. J Allergy Clin Immunol 1994;93:1060-7.
54. Altman LC, Ayars GH, Baker C, Luchtel DL. Cytokines and eosinophil derived cationic proteins up-regulate intercellular adhesion molecule 1 on human nasal epithelial cells. J Allergy Clin Immunol 1993;92:527-36.
55. Mullol J, Chowdoury BA, White MV, et al. Endothelin in human nasal mucosa. Am J Respir Cell Mol Biol 1993;8:393-402.
56. Furukawa K, Saleh D, Bayan F, et al. Coexpression of endothelin 1 and endothelin converting enzyme 1 in patients with chronic rhinitis. Am J Respir Cell Mol Biol 1996;14:248-53.
57. Martin U, Bryden K, Devoy M, Howarth P. Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunol 1996;97:768-72.
58. Fischer A, Hoffman B. Nitric oxide synthase in neurons and nerve fibres of lower airways and in vagal sensory ganglia of man. Am J Respir Crit Care Med 1996;154:209-16.
59. Masuda S. Quantitative histochemistry of mucus-secreting cells in human nasal mucosa. Pract Otol (Kyoto) 1990;83:1855-63.
60. White MV. Nasal cholinergic hyperresponsiveness in atopic subjects studied out of season. J Allergy Clin Immunol 1993;92:278-87.
61. Baroody FM, Cruz AA, Lichenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM. Intranasal beclomethasone inhibits antigen induced nasal hyperresponsiveness to histamine. J Allergy Clin Immunol 1992;90:373-6.
62. Riccio MM, Proud D. Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes. J Allergy Clin Immunol 1996;97:1252-63.
63. Druce HM, Wright RH, Kossoff D, Kaliner MA. Cholinergic nasal hyperreactivity in atopic subjects. J Allergy Clin Immunol 1985;76:445-52.
64. de Graaf-in't Veld C, Garrelds IM, Jansen APH, et al. Effect of intranasal fluticasone propionate on the immediate and late allergic reaction and nasal hyperreactivity in patients with house dust mite allergy. Clin Exp Allergy 1995;25:966-73.
65. Bradding P, Feather IH, Wilson S, Holgate ST, Howarth PH. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am J Respir Crit Care Med 1995;151:1900-6.
66. Baraniuk JN. Glucocorticoids: bench to bedside. J Allergy Clin Immunol 1996;97:141-82.
67. Iliopoulos O, Proud D, Adkinson F Jr, et al. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991;87:855-66.
68. Durham SR, Kay AB, Hamid Q. Changes in allergic inflammation associated with successful immunotherapy. Int Arch Allergy Immunol 1995;107:282-4.
69. Durham SR, Ying S, Varney VA, et al. Grass pollen immunotherapy inhibits allergen induced infiltration of CD4+, T lymphocytes, and pathology of eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for Interferon gamma. J Allergy Clin Immunol 1996;97:1356-65.